MedTrace Logo

Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects

NCT03279341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-09-12

No results posted yet for this study

Summary

This study aim was to evaluate the effect of pharmacological treatments normally used to treat functional constipation and in particular PEG, bisacodyl and prucalopride on colonic motility as assessed by high-resolution manometry.

Conditions

  • Chronic Constipation

Interventions

DRUG

polyethylene glycol

osmotic laxative

DRUG

Bisacodyl

stimulant laxative

DRUG

Prucalopride

prokinetic

Sponsors & Collaborators

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Jan Tack, MD. PhD · KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-03
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03279341 on ClinicalTrials.gov